Quick question...
Would you spend 60 seconds to save yourself $29.97?
That's what my "Safe Trade Options Formula" book costs on our website right now. But today, I'm giving it away — no charge, no strings.
Inside, you'll discover a 5-part trade that makes every trade... a SAFE TRADE.
It's the same book that sells for $29.97 on our website right now, but is yours on the house today.
All you have to do is click here and tell me where to send it.
Good Trading,
Bill Poulos
p.s. This won't stay free forever — $29.97 is a fair price and I'll be going back to it soon.
Grab your copy here before that happens.
Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Written by Leo Miller. Date Posted: 5/27/2026.
Key Points
- Keysight Technologies is putting up big-time gains, with shares more than doubling since the start of 2025.
- The firm plays in two of the economy's top growth areas: artificial intelligence and defense.
- After beating and raising during its latest quarter, analysts lifted their Keysight price targets substantially.
- Special Report: Elon Musk: This Could Turn $100 into $100,000
Keysight Technologies (NYSE: KEYS) sits at the intersection of two major economic trends: the artificial intelligence (AI) buildout and defense modernization.
With those tailwinds behind it, Keysight shares have performed exceptionally well in recent months. Since the start of 2025, the stock has climbed more than 100%, and in 2026, shares have added about 70%.
Before SpaceX goes public, watch this tiny supplier closely (Ad)
When the railroads launched in the 1860s, Andrew Carnegie didn't profit by riding the trains - he got rich owning the steel rails they ran on. The same dynamic may be playing out today around the anticipated $1.75 trillion SpaceX IPO.
Analyst Michael Robinson has identified a tiny, under-the-radar supplier - just 1/60th the size of SpaceX - that he believes sits at the center of Elon Musk's broader AI infrastructure buildout. Once SpaceX goes public this June, Robinson argues Wall Street will inevitably spotlight this overlooked vendor.
Watch Robinson's presentation and see the details before the IPO window closesKeysight spiked 23% after its February earnings report, pushing the stock close to $300 per share. Since then, the shares have continued to rise and now trade nearer to $350. Keysight just released its fiscal second-quarter earnings, and the results were the best in company history. Although the stock did not get much of a lift from the market, Wall Street price targets moved sharply higher. Following the report, analysts raised their targets meaningfully, signaling support for the continuation of Keysight’s impressive run.
Keysight Wallops Adjusted EPS Estimates, Issues Large Guidance Raise
In its report, Keysight posted revenue of $1.72 billion, an increase of just over 31% year over year (YOY). (Note that Keysight reports fiscal results slightly ahead of the calendar year.) This marked the company’s fastest revenue growth rate in five years, since sales rose 36% YOY in early 2021. Revenue also slightly beat estimates of $1.71 billion.
The much larger beat came on the bottom line. Keysight saw adjusted earnings per share (EPS) rise a massive 69% YOY to $2.87. Analysts had forecast $2.32, implying growth of only 36% YOY. Still, it is important to note that a $96 million tariff refund significantly boosted adjusted EPS. Without that benefit, the company still would have beaten estimates, but by a much smaller margin. The tariff refund still benefits Keysight, but it is a factor outside the firm’s control.
Orders grew even more impressively than sales, rising 56% YOY to more than $2 billion—a strong sign for the company’s growth outlook. Given these results, Keysight raised its full-year fiscal 2026 guidance and now expects revenue growth in the high-20% range. That is a meaningful increase from prior expectations of “growth just above 20%.”
Strength was broad-based across Keysight’s end markets. Commercial Communications, which includes much of its data center and AI-related revenue, rose 40% YOY. That was a solid acceleration from 33% YOY growth in the prior quarter. Meanwhile, Aerospace, Defense & Government saw sales increase 24% YOY, up from 18% YOY last quarter. Electronic Industrial Solutions, which includes some semiconductor revenue, rose 24% YOY, also a solid improvement from 15% growth last quarter.
Keysight Shares Didn’t Budge, But Price Targets Moved Way Up
Despite the strong earnings report, Keysight shares were nearly unchanged afterward, slipping 0.6%. This likely reflects the fact that the tariff benefit contributed significantly to the adjusted EPS beat. In addition, shares had already risen 14% since the company’s last post-earnings spike, suggesting investors had priced in strong results.
Even so, Wall Street analysts sharply increased their forecasts for the stock after the report. Overall, among analysts for whom MarketBeat had previous price target data, the average price target moved up 15% to $391. That figure sits notably above the MarketBeat consensus price target of $372. Using the updated average price target, the implied upside in Keysight stock is close to 10%.
Ten percent upside is not especially exciting. However, the more important point is that Keysight continues to exceed analysts' expectations. The company has beaten estimates on both sales and adjusted EPS in 11 of its last 12 reports.
As a result, Wall Street forecasters have had little choice but to move their targets higher as Keysight shows its business is firing on all cylinders. When a stock performs this well, analysts often have to play catch-up, and implied upside figures do not always tell the full story.
Keysight: Strong Fundamental Improvement Versus Elevated Valuation
Keysight currently trades at a forward price-to-earnings (P/E) ratio near 43x. That is significantly higher than its average forward P/E of 23x over the past three years. While the valuation is clearly elevated relative to history, it is also difficult to argue with the results Keysight is delivering. The company is growing at a pace not seen in years, and profits are rising rapidly even without the tariff benefit. Given the strong underlying tailwinds in AI and defense supporting Keysight’s growth, it would not be surprising to see the stock continue to perform well.
Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Written by Thomas Hughes. Date Posted: 6/2/2026.
Key Points
- Insiders at HeartBeam, Sportradar, and Granite Ridge Resources are aggressively buying shares, signaling confidence despite distinct risks at each company.
- HeartBeam analysts see up to 390% upside as the med-tech firm nears commercialization of its ECG device, though cash burn and adoption hurdles remain.
- Granite Ridge's nearly 9% dividend yield attracts insider buying, but a consensus Reduce rating and dividend sustainability concerns tied to cash burn pose meaningful risks.
- Special Report: Elon Musk: This Could Turn $100 into $100,000
Insiders are aggressively buying stocks like HeartBeam (NASDAQ: BEAT), Sportradar Group (NYSE: SRAD), and Granite Ridge Resources (NYSE: GRNT), highlighting three very different risk/reward setups.
While risks are present, the upside potential is compelling. The question is whether these companies can execute their strategies, navigate headwinds, and prove their naysayers wrong. Any missteps or unexpected hurdles will be reflected in their stock prices.
HeartBeam: A Heartbeat Away From Higher Prices
Before SpaceX goes public, watch this tiny supplier closely (Ad)
When the railroads launched in the 1860s, Andrew Carnegie didn't profit by riding the trains - he got rich owning the steel rails they ran on. The same dynamic may be playing out today around the anticipated $1.75 trillion SpaceX IPO.
Analyst Michael Robinson has identified a tiny, under-the-radar supplier - just 1/60th the size of SpaceX - that he believes sits at the center of Elon Musk's broader AI infrastructure buildout. Once SpaceX goes public this June, Robinson argues Wall Street will inevitably spotlight this overlooked vendor.
Watch Robinson's presentation and see the details before the IPO window closesHeartBeam is an emerging med-tech start-up on the cusp of commercializing its technology, which includes a credit-card-sized electrocardiogram (ECG) device.
Initial FDA clearances have been granted, setting the stage for revenue to begin this year. The primary catalyst is sales growth, but there are hurdles to overcome—specifically, convincing heart clinics to adopt the new system and securing FDA approval for expanded use, including at-home use.
Insiders buying shares include several directors and the CFO, who bought in tandem and took advantage of a public offering rather than purchasing on the open market.
Their actions signal confidence in the outlook, help offset the new dilution, and are echoed by analysts and institutions. The stock has a consensus Moderate Buy rating from the eight analysts who cover HeartBeam, with a 60% Buy-side bias and 390% upside at the consensus price target. Even the lowest price target still implies substantial upside of about 185%, suggesting strong potential.
The primary risk is cash burn. The recent offering helped bolster the balance sheet, providing a clear runway through year-end, but it does not eliminate the possibility of a future capital raise. Other risks include slower-than-expected adoption and revenue growth, regulatory hurdles, and the potential for recall. Factors that may affect adoption include insurance reimbursement rates, which influence end-user profitability. Additional risks include low liquidity in the stock and the potential for violent price swings.
Sportradar: Insider Buying Meets Short-Seller Pressure
Sportradar’s stock price is oversold and may be poised to rebound by mid-2026, but the company faces risks in its market. It is not only dealing with regulatory scrutiny related to prior years, but also a short-seller report that has raised concerns. Short-sellers allege that the company's business is rooted in black-and-gray sports-betting markets, creating the risk of lost legitimate business and license cancellations.
Insiders buying stock include several directors and the CEO, who made multiple purchases in Q2. They own approximately 4% of the stock and have significant skin in the game. Their purchases are reinforced by institutions that own more than 50% of the stock and have been aggressively accumulating shares.
While some institutions have sold, more have bought, leading to a trailing-12-month balance of approximately $1.5 to $1 in favor of buying, with activity accelerating in Q2. The Q2 activity shows primarily buying, at a pace of more than $10 to $1.
Analyst sentiment trends have contributed to SRAD’s price decline, but the stock has outpaced that trend. As it stands, SRAD stock has a consensus Moderate Buy rating from the 19 analysts who cover it, with a 68% Buy-side bias and more than 75% upside at the consensus price target.
While the trend points to the low end, most revisions still assume substantial double-digit upside, and the low target establishes a price floor that has yet to be broken.
Granite Ridge: Insiders Buy High Yield
Granite Ridge is a non-operated oil exploration and production company with a portfolio of properties in key U.S. production regions. The company partners with proven operators, relying on them to maintain crews and field operations while generating revenue from its share of oil production.
Insiders are buying in 2026 to signal confidence in the cash flow, the stock's low valuation, and dividend safety. The dividend is a critical factor, as this stock yields nearly 9%. Insiders who bought include several directors, the CEO, and the CFO. The group collectively owns about 8% of the stock.
Institutions are also buying. They own only 30% of the shares but provide meaningful support, buying at a pace of more than $2 to $1.
Analysts, however, are less bullish on the stock, with recent downgrades resulting in a consensus Reduce rating. The single analyst that issued a price target calls for more than 100% upside relative to the consensus.
The biggest risk is cash flow and cash burn. While the company is well-capitalized and generating healthy cash flow, its aggressive growth strategy is burning cash as costs rise. The risk is to the dividend, which is well above 100% of earnings.
Chart action suggests a bottom for this market and the potential for a rebound. The caveat is that a range has formed and upside is limited. The likely outcome is that this market remains below $6 in 2026.
This email communication is a sponsored email from Profits Run, a third-party advertiser of The Early Bird and MarketBeat.
If you need assistance with your subscription, feel free to contact MarketBeat's South Dakota based support team at contact@marketbeat.com.
If you no longer wish to receive email from The Early Bird, you can unsubscribe.
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 N Reid Pl., Sixth Floor, Sioux Falls, S.D. 57103-7078. United States of America..
No comments:
Post a Comment